International lawyers and advisers have switched their focus from US and European antitrust regulators to those within China as competition watchdogs maintain a firm obstacle to merger approval. According to one analyst, mergers are often delayed due to the nation’s anti-monopoly law, passed just five years ago. As companies look to expand in the globe’s second-largest economy, multi-billion dollar mergers are at stake as recently-implemented legislation reworks the system. Regulators in Beijing, for example, only recently approved of a $5.6 billion acquisition of US-based grain company Gavilon by Japan-based Marubeni Corp., which endured a year-long review. Additionally, Chinese regulators forced steep divestures upon Glencore in its $30 billion buyout of Xstrata after a 14-month battle. According to some analysts, the difficulty of Chinese antitrust regulators may stem from their tendency to focus on industrial policy protection, rather than consumer protection, when reviewing merger cases.
Featured News
The Hidden Security Risk Inside Your Company’s AI Tools
Mar 13, 2026 by
CPI
EU’s Largest Economies Push to Reduce Reliance on Foreign Payment Systems
Mar 12, 2026 by
CPI
Warren Presses Amazon for Answers on Pricing Practices for Government Buyers
Mar 12, 2026 by
CPI
EU Antitrust Chief Raises Concerns Over Big Tech Control of AI
Mar 12, 2026 by
CPI
Burson Adds Senior Advisor to Strengthen Competition Team
Mar 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece